Navigation Links
Coinstar to Invest in SoloHealth
Date:3/21/2011

BELLEVUE, Wash., March 21, 2011 /PRNewswire/ -- Coinstar, Inc. (Nasdaq: CSTR) today announced it will invest in SoloHealth, a consumer-driven healthcare technology company that develops and deploys health screening and information kiosks, including its award-winning EyeSite® product and the next-generation SoloHealth Station™.  Investment details were not disclosed.

"As a leader in automated retail, Coinstar is continually looking for kiosk concepts that are innovative and compelling," said Gregg Kaplan, president and chief operating officer of Coinstar, Inc.  "We believe that SoloHealth will address the changing market dynamics in the healthcare space by bringing free health and wellness screening to individuals who may not have accessed it otherwise."

In development, SoloHealth's next-generation, comprehensive SoloHealth Station will screen vision, blood pressure, weight, and body mass index, and provide an overall health assessment free of charge. It also gives consumers access to a database of local doctors.  The company plans to provide highly personalized and interactive healthcare opportunities for consumers, advertisers and retailers by placing kiosks in high-traffic retail locations and connecting them to SoloHealth's multi-platform ecosystem across retail, online/digital, mobile and emerging platforms.  

"We are thrilled to have the support of Coinstar, a leader in automated retail," said Bart Foster, chief executive officer and founder of SoloHealth.  "We live in a self-service society, and with the current environment, we believe SoloHealth's platforms will provide a tremendous resource for consumers and the entire healthcare system by reducing healthcare costs, increasing access and empowering people to take action to improve their lives."

About Coinstar, Inc.

Coinstar, Inc. (NASDAQ: CSTR) is a leading provider of automated retail solutions offering convenient services that make life easier for consumers and drive incremental traffic and revenue for retailers. The company's core automated retail businesses include the well-known redbox® self-service DVD rental and Coinstar® self-service coin-counting brands. The company has approximately 30,200 DVD kiosks and 18,900 coin-counting kiosks in supermarkets, drug stores, mass merchants, financial institutions, convenience stores, and restaurants. For more information, visit www.coinstarinc.com.

About SoloHealth

Based in Atlanta, Ga., SoloHealth is a leader in self-service consumer healthcare, utilizing technology to develop and deploy interactive healthcare platforms and kiosks to empower consumers to take charge of their health through awareness, education and action.  The award-winning company's first offering was the EyeSite® vision kiosk, currently located in numerous retail outlets across America.  In summer 2010, the company received a $1.2 million grant from the National Institutes of Health (NIH), a division of the U.S. Department of Health and Human Services, to help enable innovation for the next-generation health and wellness platforms for healthcare and prevention. The company's bilingual kiosks provide free health screenings and recommendations for follow-up care, as well as health and wellness information, which leads to prevention and lower healthcare costs.  For more information, visit www.solohealth.com.  

Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including phrases conveying expectation or intent and other expressions identifying future performance. These forward-looking statements are subject to a number of substantial risks and uncertainties and may be identified by the words "believe," "continually," "will," "anticipate," "expect," "may," or "intend," or similar expressions, but their absence does not mean that the statement is not forward-looking.  Forward-looking statements are not guarantees of future performance which may vary materially from performance expressed or implied in the forward-looking statements. Differences may result from actions taken by Coinstar, Inc. as well as those of third parties and from risks and uncertainties beyond Coinstar, Inc.'s control. Such risks and uncertainties include, but are not limited to, the effect of Coinstar, Inc.'s investment in SoloHealth, and the ability to adequately evaluate new automated retail concepts. The foregoing risks and uncertainties are illustrative, but by no means exhaustive. For more information on factors that may affect future performance, please review "Risk Factors" described in our most recent Form 10-K filed with the Securities and Exchange Commission. These forward-looking statements reflect Coinstar, Inc.'s expectations as of the date of this release. Coinstar, Inc. undertakes no obligation to update the information provided herein.


'/>"/>
SOURCE Coinstar, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Yongye Biotechnology International Retains CCG Investor Relations
2. MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments
3. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for Cancer Therapy Based on Targeting a Biomarker by Novel Investigational Agents
4. BD to Present at Investor Healthcare Conferences
5. Abaxis, Inc. to Present at the Sidoti & Companys Seventh Annual West Coast Emerging Growth Institutional Investor Forum
6. Orexigen(R) Therapeutics to Present at Upcoming Investor Conferences
7. Carilion Clinic Invests in Sight Saving Technology to Improve Patient Care: Carilion Clinic Teams Up with Retasure
8. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Conference
9. Accuray Incorporated to Host Investor and Analyst Meeting at ASTRO
10. American Oriental Bioengineering Announces Participation in September Investor Conferences
11. Abbott to Present at UBS Best of Americas Investment Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 24, 2017  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), ... a Key Opinion Leader event to highlight new clinical ... poster presentation at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium ... will be held in-person and via live webcast on ... AM PST at the Lotte New York Palace Hotel ...
(Date:2/23/2017)... , Feb. 23, 2017 /PRNewswire/ - The Fight Against ... Cancer Research (OICR) are pleased to report that Fusion ... financing, with Johnson & Johnson Innovation – JJDC, Inc. ... venture groups HealthCap, TPG Biotechnology Partners, and Genesys Capital, ... ...
(Date:2/23/2017)... , Feb. 23, 2017  Imanis Life Sciences ... line of oncolytic vaccinia viruses for virotherapy research. ... part of Genelux,s proprietary, vaccinia virus-based technology platform ... to enter into a partnership with Genelux to ... vaccinia viruses for use in research," said Dr. ...
(Date:2/23/2017)... ... ... Today, researchers can fast-track sample collection and analysis for ... or SNPs of interest) using one, easy-to-collect saliva sample. With the addition of ... and other relevant biomarkers can be extensively studied through a non-invasive sample type. ...
Breaking Biology Technology:
(Date:2/8/2017)... , Feb. 7, 2017 The biometrics ... by the confluence of organizations, desires to better ... knowledge-based systems (password and challenge questions), biometrics is ... government systems. The market is driven by use ... between consumer and enterprise uses cases, with consumer-facing ...
(Date:2/7/2017)... February 7, 2017 Ipsidy Inc. ... Corporation [OTC: IDGS], ("Ipsidy" or the "Company") a provider ... processing services, is pleased to announce the following changes ... Effective January 31, 2017, Philip D. Beck ... CEO and President.  An experienced payment industry professional and ...
(Date:2/2/2017)... Fla. , Feb. 2, 2017   ... a clinical-stage immuno-oncology company specializing in the development ... for the treatment of cancer and metastatic disease, ... scale-up and GMP manufacturing of a second clinical ... vaccine targeting folate receptor alpha. The manufactured vaccine ...
Breaking Biology News(10 mins):